NET LOSS PER SHARE - Additional Information (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 18, 2026 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Issuable shares | 25,864,651 | 24,907,407 | |
| Loan Agreement | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Borrowed amount | $ 0 | $ 15,000,000 | |
| Loan Agreement | Additional Warrants | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Borrowed amount | $ 0 | ||
| Issuable shares | 0 | ||
| Class A Common Stock | Loan Agreement | Additional Warrants | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Warrants | 520,835 | ||
| Warrants, exercise price | $ 1.2 | ||